Hello and welcome to another edition of “Best 5 Reads”.
Today we will be discussing the consensus statement which was issued by prominent psychiatrists on how to manage Bipolar Disorder during and after pregnancy. It touches upon how to treat Bipolar on trimester basis. It also discussed the potential side effects of commonly used medications on the baby.
In addition, we will also talk about the effect of anorexia on bones, effect of maternal depression on the child development, debate among doctors on physician assisted suicide, and illegal use of Kratom products.
1) Management of Bipolar Disorder During Pregnancy and the Postpartum Period
Since treatment can be managed most effectively if pregnancy is planned, clinicians should discuss the issue of pregnancy and its management with every patient with bipolar disorder who has childbearing potential, regardless of future reproductive plans.
2) Effects of the Two Types of Anorexia Nervosa on Bone Metabolism
Study findings demonstrate that individuals with restrictive anorexia present with more severe undernutrition than those with binge/purge anorexia, characterized by lower body mass index, resting energy expenditure, whole body fat-free soft tissue, and percentage of body fat mass.
3) Associations Between Maternal Depression, Support, and Cognitive Development in Offspring
Mothers with severe depression provided less learning-material and emotional support to their children. Furthermore, low maternal support was more strongly linked to maternal depression as children got older, according to a study published in Child Development.
Study findings indicate that more frequent depressive symptoms seemed to reduce the mothers’ emotional and material investment in their children, which in turn limited their children’s cognitive development.
Study investigators concluded that considering how widespread maternal depression is, it is crucial to identify and treat the condition early. These findings also suggest that there are long-term adverse effects of maternal depression on child development.
4) Will the AMA Heed Its Own Ethics Council, Regarding Assisted Suicide?
The thorny issue of “end-of-life care” is likely to remain controversial in the US, with physicians themselves holding a wide variety of views.
5) FDA Warns Kratom Makers Over Illegal Sales, Deceptive Marketing
The US Food and Drug Administration (FDA) has sent warning letters to three companies for illegally selling unapproved kratom products, which they claim can treat opioid addiction and withdrawal and a whole host of other problems.
What is Kratom?
Kratom is derived from the leaves from the kratom tree (Mitragyna speciosa), which is native to Thailand, Indonesia, and Papua New Guinea. The botanical’s popularity has been increasing in the United States, with users claiming it helps treat pain, anxiety, depression, and, more recently, opioid withdrawal.
Thank you for reading today’s edition. If you have any questions or feedback, please free to use the comment box and contact form.
Best Regards,
Vikram
PsiHub 